Hereditary Hemorrhagic Telangiectasia (HHT) Center
HHS-HRSA Posted HRSA-26-092
Close Date:
July 10, 2026
Deadline passed
Description
The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) Center Program is to reduce illness and death related to HHT by partnering with clinical center to expand access and coordination of care; creating innovative strategies that support clinicians with identifying and diagnosing HHT cases; and developing a de-identified, aggregate patient data registry to better understand this rare disease and its treatment outcomes.
Eligibility
"Domestic" means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
Actions
Funding Details
- Award Floor
- Not specified
- Award Ceiling
- $2,900,000.00
- Total Estimated Funding
- $2,900,000.00
- Expected Awards
- 1
Key Dates
- Posted
- June 8, 2026
- Closes
- July 10, 2026
- Archive Date
- August 30, 2026
Agency Information
- Agency Name
- Health Resources and Services Administration
- Agency Code
- HHS-HRSA
- Funding Instrument
- Other